Table 3 The C-Index values of TNM-stage, PAAD-IRGS, nomogram and nomogram + IRGS in different cohorts.

From: Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma

Cohorts

C-Index (95% CI)

TNM-stage

PAAD-IRGS

Nomogram

Nomogram + IRGS

PAAD-OS

0.567 (0.538–0.596)

0.639 (0.609–0.670)

0.706 (0.672–0.740)

0.723 (0.690–0.756)

LIHC-OS

0.616 (0.588–0.644)

0.615 (0.588–0.644)

0.637 (0.603–0.672)

0.666 (0.630–0.701)

PAAD-DSS

0.571 (0.528–0.614)

0.680 (0.649–0.711)

0.749 (0.714–0.784)

0.775 (0.742–0.808)

PAAD-PFI

0.543 (0.508–0.578)

0.649 (0.618–0.681)

0.699 (0.664–0.733)

0.742 (0.712–0.771)

  1. C-Index concordance index, IRGS immune-related genes signature, PAAD pancreatic adenocarcinoma, LIHC liver hepatocellular carcinoma, OS overall survival, DSS disease specific survival, PFI progress free interval.
Back to article page